Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | CASP7 | P55210 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL23633149 | 0.81 | PDK2 (0.53) | PDK2MEN1MAPTKMT2AKDM4E | |
| SCHEMBL24604333 | 0.77 | KMT2A (0.38) | PDK2MEN1MAPTKMT2ANPSR1 | |
| SCHEMBL26580911 | 0.74 | PDK2 (0.54) | PDK2MEN1MAPTKMT2ANPSR1 | |
| SCHEMBL24531304 | 0.74 | PDK2 (0.48) | PDK2MEN1KMT2AKDM4ELMNA | |
| SCHEMBL74839 | 0.73 | ALDH1A1 (0.52) | KMT2ALMNAALDH1A1POLBTSHR | |
| SCHEMBL30672129 | 0.72 | PDK2 (0.42) | PDK2 | |
| SCHEMBL29137464 | 0.72 | PDK2 (0.42) | PDK2 | |
| SCHEMBL30076231 | 0.72 | ALDH1A1 (0.43) | MEN1MAPTKMT2ANPSR1KDM4E | |
| SCHEMBL28854435 | 0.72 | PDK2 (0.52) | PDK2MEN1KMT2AKDM4ELMNA | |
| SCHEMBL29897944 | 0.72 | PDK2 (0.52) | PDK2MEN1KMT2AKDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147442-A1 | ORGANIC COMPOUND, ELECTROLUMINESCENT MATERIAL, AND APPLICATION THEREOF | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210147442-A1 | ORGANIC COMPOUND, ELECTROLUMINESCENT MATERIAL, AND APPLICATION THEREOF | ILK, OSTC, LEF1 | PDK2 1076/4885MEN1 2310/4885MAPT 506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.